Published in Oncoscience on February 20, 2015
Precision medicine from the renal cancer genome. Nat Rev Nephrol (2016) 0.80
Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features. Cancers (Basel) (2017) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Molecular portraits of human breast tumours. Nature (2000) 94.14
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Signatures of mutational processes in human cancer. Nature (2013) 21.63
International network of cancer genome projects. Nature (2010) 20.35
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet (2013) 11.29
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
A promoter-level mammalian expression atlas. Nature (2014) 6.25
The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol (2010) 5.04
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell (2014) 4.17
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 3.85
Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol (2002) 3.52
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet (2014) 2.86
Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet (2001) 2.68
The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell (2014) 2.21
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell (2011) 2.12
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet (2014) 2.06
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell (2013) 2.00
In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab (2013) 1.93
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet (2005) 1.90
Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1985) 1.71
Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A (2012) 1.63
Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol (1994) 1.62
Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol (2008) 1.60
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat Genet (2014) 1.58
TERT promoter mutations in cancer development. Curr Opin Genet Dev (2013) 1.58
A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet (2009) 1.56
Efficient selection and characterization of mutants of a human cell line which are defective in mitochondrial DNA-encoded subunits of respiratory NADH dehydrogenase. Mol Cell Biol (1995) 1.35
Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res (2008) 1.34
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet (2007) 1.27
Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol (2000) 1.25
Of mice and men: divergence of gene expression patterns in kidney. PLoS One (2012) 1.15
Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. Am J Surg Pathol (2011) 1.11
The metabolic basis of kidney cancer. Semin Cancer Biol (2012) 1.09
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. Br J Cancer (2006) 1.08
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics (2010) 1.06
Segmental disorders of the nephron: histopathological and imaging perspective. Br J Radiol (2007) 1.01
Rearrangement of upstream sequences of the hTERT gene during cellular immortalization. Genes Chromosomes Cancer (2009) 1.00
Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis (2003) 0.99
Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol (2013) 0.99
Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell carcinoma. Clin Nucl Med (2012) 0.97
Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int J Cancer (2004) 0.94
Kidney cancer. Urol Oncol (2012) 0.91
CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. BMC Clin Pathol (2009) 0.86